CIIT vs TMO · rev $9.3M vs P/E 24, rev $44.56B
Tianci International, Inc. Common Stock (CIIT) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Tianci International, Inc. Common Stock (CIIT) is a integrated freight & logistics company listed on NASDAQ.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported CIIT revenue for 2025-07-31 was $9.3M. Net income was -$2.7M. Revenue was up 7.7% from 2024-07-31 to 2025-07-31. CIIT currently screens at market cap $2.1M.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
CIIT currently screens at market cap $2.1M. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the CIIT and TMO stock pages for the full models.
Not investment advice.